Publications by authors named "Carl Cardella"

Claim this Profile
O
Outcomes of keratolimbal allograft from ABO compatible donors for severe bilateral limbal stem cell deficiency.
Michael Mimouni, Edward Cole, S Joseph Kim, Jeffrey Schiff, Carl Cardella

Ocul Surf· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Canagliflozin in Kidney Transplant Recipients for the Treatment of Type 2 Diabetes: A Case Series.
Harindra Rajasekeran, S Joseph Kim, Carl J Cardella, Jeffrey Schiff, Mark Cattral

Diabetes Care· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot study of reduced dose cyclosporine and corticosteroids to reduce new onset diabetes mellitus and acute rejection in kidney transplant recipients.
Edward H Cole, G V Ramesh Prasad, Carl J Cardella, Joseph S Kim, Kathryn J Tinckam

Transplant Res· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal cell carcinoma in the native and allograft kidneys of renal transplant recipients.
Michael Leveridge, Mireia Musquera, Andrew Evans, Carl Cardella, York Pei

J Urol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delayed graft function and the risk of death with graft function in living donor kidney transplant recipients.
Ranjit Narayanan, Carl J Cardella, Daniel C Cattran, Edward H Cole, Kathryn J Tinckam

Am J Kidney Dis· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The CLEAR study: a 5-day, 3-g loading dose of mycophenolate mofetil versus standard 2-g dosing in renal transplantation.
Sita Gourishankar, Isabelle Houde, Paul A Keown, David Landsberg, Carl J Cardella

Clin J Am Soc Nephrol· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delayed graft function and the risk for death with a functioning graft.
Shruti N Tapiawala, Kathryn J Tinckam, Carl J Cardella, Jeffrey Schiff, Daniel C Cattran

J Am Soc Nephrol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of immunoglobulin therapy for patients undergoing solid organ transplantation: an evidence-based practice guideline.
Nadine Shehata, Valerie A Palda, Ralph M Meyer, Tom D Blydt-Hansen, Patricia Campbell, Carl Cardella

Transfus Med Rev· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of deceased donor diabetes mellitus on kidney transplant outcomes: a propensity score-matched study.
Mufazzal Ahmad, Edward H Cole, Carl J Cardella, Daniel C Cattran, Jeffrey Schiff

Transplantation· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-year study of tacrolimus as secondary intervention versus continuation of cyclosporine in renal transplant patients at risk for chronic renal allograft failure.
Anthony Jevnikar, Dianne Arlen, Brendan Barrett, Anne Boucher, Carl Cardella

Transplantation· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal transplant outcome in high-cardiovascular risk recipients.
Tarun K Jeloka, Heather Ross, Robert Smith, Michael Huang, Stanley Fenton, Carl Cardella

Clin Transplant· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A report of the Lisbon Conference on the care of the kidney transplant recipient.
Mario Abbud-Filho, Patricia L Adams, Josefina Alberú, Carl Cardella, Jeremy Chapman

Transplantation· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of the effects of C2-cyclosporine and C0-tacrolimus on renal function and cardiovascular risk factors in kidney transplant recipients.
S Joseph Kim, G V Ramesh Prasad, Michael Huang, Michelle M Nash, Olusegun Famure, Carl J Cardella

Transplantation· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of anti-non-Gal antibodies in the development of acute humoral xenograft rejection of hDAF transgenic porcine kidneys in baboons receiving anti-Gal antibody neutralization therapy.
Gang Chen, Hongtao Sun, Hongji Yang, Dalibor Kubelik, Bertha Garcia, Carl J Cardella

Transplantation· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abnormal B-cell regulation in highly sensitized patients with sustained serum levels of antibody to HLA class I antigens.
Nashrudeen Hack, Sarita Angra, Theresa L McKnight, Neal den Hollander, Carl J Cardella

Transplantation· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced incidence of new-onset diabetes mellitus after renal transplantation with 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors (statins).
G V Ramesh Prasad, S Joseph Kim, Michael Huang, Michelle M Nash, Jeffrey S Zaltzman, Carl J Cardella

Am J Transplant· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical benefits of neoral C2 monitoring in the long-term management of renal transplant recipients.
Edward Cole, Nava Maham, Carl Cardella, Daniel Cattran, Stanley Fenton

Transplantation· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement in rejection of human decay accelerating factor transgenic pig-to-primate renal xenografts with administration of rabbit antithymocyte serum.
Anand Ghanekar, Ginette Lajoie, Yigang Luo, Hongji Yang, Jinsub Choi, Carl J Cardella

Transplantation· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-idiotypic antibodies from highly sensitized patients stimulate B cells to produce anti-HLA antibodies.
Nashrudeen Hack, Sarita Angra, Eva Friedman, Theresa McKnight, Carl J Cardella

Transplantation· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Probable interaction between efavirenz and cyclosporine.
Alice Tseng, Mary E Nguyen, Carl Cardella, Atul Humar, John Conly

AIDS· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis